A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes [...]
A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]
A mid pharma client based in Germany, involved in late-stage development of a therapy for PID, with effective marketing [...]
A large medical device client, based in the United States, with capabilities in drug delivery medical devices, involved DelveInsight to assess the potential risks and benefits of a... [...]